Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07631468

PROspect Registry :Post Market Clinical Follow-up Study

Retrospective, multi-center, chart review (only to include data that is part of the surgeons' standard practice)

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Tufts Medical Center

Boston, Massachusetts, 02111, United States

Location contact

Abhishek Chatterjee Principle Investigator

CONTACT

[email protected]

About this study

The purpose of this study is to leverage standard of care data on clinical outcomes following surgical procedures as indicated for each device.

  • Performance Objective: To collect clinical outcomes and Patient Reported Outcome Measures (PROMs) data (as applicable) on subjects that have undergone surgical breast procedures utilizing one or more Stryker devices.
  • Safety Objective: To collect data on safety events on the use of Stryker devices and/or related procedures

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject was ≥ 18 years of age at the time of the surgery
  • Patients who have undergone breast surgical procedures using MOLLI, SPY-PHI, and/or SPY AGENT GREEN

Exclusion criteria

  • Subjects who are less than 1-month post-intervention
  • Concurrent participation in an interventional investigational clinical study at the time of initial surgery
  • Subjects whose surgery date was prior to January 2022.
  • Pregnant or lactating females at the time of initial surgery

Treatment and study plan

Standard of care treatment

Device

Subject has undergone breast surgical procedures using one of the study devices and meets eligibility criteria

Primary outcomes

  1. Successful marker localization

    Time frame: From the start of surgery to completion of surgery for each participant (assessed intraoperatively, up to the duration of the surgical procedure, typically within the same day)

    (proportion of MOLLI markers that are detected intraoperatively)

  2. Marker retrieval success

    Time frame: From the start of surgery to completion of surgery for each participant (assessed intraoperatively, up to the duration of the surgical procedure, typically within the same day)

    (proportion of procedures in which the MOLLI marker is removed within the surgical specimen)

Study contacts

Contact information is provided by the study sponsor or research team.

Colleen Roden

CONTACT

[email protected]

9312672041

Prajakta Sawwalakhe, MD

CONTACT

[email protected]

16692077970

Sponsors and collaborators

Lead sponsor

Stryker Endoscopy

Industry

Registry information

Official study title

A Retrospective, Multi-center, Post-market Registry Study of Surgical Procedures in Endoscopy, Breast, and Urology (PROspect)

Important dates

Study start
2026
Primary completion
2031
Study completion
2031
First posted
Jun 8, 2026
Registry last updated
Jun 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.